AAAAAA

   
Results: 1-23 |
Results: 23
ANALYSIS OF VARIABLES ASSOCIATED WITH RECURRENCE METASTASIS IN BREAST-CANCER TUMOR OF LESS-THAN-OR-EQUAL-TO-1 CM/
Authors: TUBIANAHULIN M HACENE K CVITKOVICBERTHREAULT F
Citation: M. Tubianahulin et al., ANALYSIS OF VARIABLES ASSOCIATED WITH RECURRENCE METASTASIS IN BREAST-CANCER TUMOR OF LESS-THAN-OR-EQUAL-TO-1 CM/, European journal of cancer, 34, 1998, pp. 448-448
ALTERNATING AND SEQUENTIAL SCHEDULES OF TAXOTERE FEC-75 IN THE FIRST LINE TREATMENT OF METASTATIC BREAST-CANCER/
Authors: TUBIANAHULIN M NAMER M TUBIANAMATHIEU N PIOT G EYMARD JC BOUGNOUX P CULINE S MANSOURI H BOCCARA C SPIELMANN M
Citation: M. Tubianahulin et al., ALTERNATING AND SEQUENTIAL SCHEDULES OF TAXOTERE FEC-75 IN THE FIRST LINE TREATMENT OF METASTATIC BREAST-CANCER/, Annals of oncology, 9, 1998, pp. 570-570
A DOSE-FINDING AND PHARMACOKINETIC (PK) PHASE-I STUDY OF A NEW FORMULATION OF DOCETAXEL (D) IN ADVANCED SOLID TUMORS
Authors: FUMOLEAU P TUBIANAHULIN M SOULIE P DELECROIX V SISTAC F MEFTI F SOULAS F APPIA F LEBECQ A VERGNIOL JC VERNILLET L RIVA A
Citation: P. Fumoleau et al., A DOSE-FINDING AND PHARMACOKINETIC (PK) PHASE-I STUDY OF A NEW FORMULATION OF DOCETAXEL (D) IN ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 387-387
PROGNOSTIC FACTORS IN SMALL BREAST-TUMORS AT THE RENE-HUGUENIN CENTER
Authors: TUBIANAHULIN M HACENE K BERTHEAULTCVITKOVIC F
Citation: M. Tubianahulin et al., PROGNOSTIC FACTORS IN SMALL BREAST-TUMORS AT THE RENE-HUGUENIN CENTER, La Semaine des hopitaux de Paris, 74(31-32), 1998, pp. 1178-1179
MITOMYCIN-VINORELBINE AS 2ND LINE CHEMOTHERAPY IN METASTATIC BREAST-CANCER
Authors: BOURGEOIS H TURPIN F BOUCHADA M VOLTERS A CVITKOVIC F GOUPIL A JANVIER M TUBIANAHULIN M SOULIE P BERLIE J GIRARD M ROUESSE J
Citation: H. Bourgeois et al., MITOMYCIN-VINORELBINE AS 2ND LINE CHEMOTHERAPY IN METASTATIC BREAST-CANCER, Bulletin du cancer, 85(9), 1998, pp. 794-798
ADJUVANT CHEMOTHERAPY WITH AC VERSUS HIGH-DOSE MITOXANTRONE, CYCLOPHOSPHAMIDE (MC), FILGRASTRIM IN OPERABLE BREAST-CANCER INVOLVING 10 OR MORE AXILLARY LYMPH-NODES - 3 YEARS FOLLOW-UP RESULTS
Authors: FUMOLEAU P CHAUVIN F NAMER M BUGAT R TUBIANAHULIN M GUASTALLA JP DELOZIER T KERBRAT P DEVAUX Y FILLEUL A
Citation: P. Fumoleau et al., ADJUVANT CHEMOTHERAPY WITH AC VERSUS HIGH-DOSE MITOXANTRONE, CYCLOPHOSPHAMIDE (MC), FILGRASTRIM IN OPERABLE BREAST-CANCER INVOLVING 10 OR MORE AXILLARY LYMPH-NODES - 3 YEARS FOLLOW-UP RESULTS, European journal of cancer, 33, 1997, pp. 351-351
PHASE-I STUDIES OF COMBINED PACLITAXEL EPIRUBICIN AND PACLITAXEL/EPIRUBICIN/CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST-CANCER - THE FRENCH EXPERIENCE/
Authors: CATIMEL G SPIELMANN M DIERAS V TUBIANAHULIN M BONNETERRE J POUILLART P KAYITALIRE L GUASTALLA JP GRAFFAND N GARET F DUMORTIER A PELLAECOSSET B
Citation: G. Catimel et al., PHASE-I STUDIES OF COMBINED PACLITAXEL EPIRUBICIN AND PACLITAXEL/EPIRUBICIN/CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST-CANCER - THE FRENCH EXPERIENCE/, Seminars in oncology, 24(1), 1997, pp. 8-12
DOSE-RESPONSE STUDY OF IBANDRONATE IN THE TREATMENT OF CANCER-ASSOCIATED HYPERCALCEMIA
Authors: RALSTON SH THIEBAUD D HERRMANN Z STEINHAUER EU THURLIMANN B WALLS J LICHINITSER MR RIZZOLI R HAGBERG H HUSS HJ TUBIANAHULIN M BODY JJ
Citation: Sh. Ralston et al., DOSE-RESPONSE STUDY OF IBANDRONATE IN THE TREATMENT OF CANCER-ASSOCIATED HYPERCALCEMIA, British Journal of Cancer, 75(2), 1997, pp. 295-300
PHENOBARBITAL ADMINISTRATION DOES NOT AFFECT HIGH-DOSE IFOSFAMIDE PHARMACOKINETICS IN HUMANS
Authors: LOKIEC F SANTONI J WEILL S TUBIANAHULIN M
Citation: F. Lokiec et al., PHENOBARBITAL ADMINISTRATION DOES NOT AFFECT HIGH-DOSE IFOSFAMIDE PHARMACOKINETICS IN HUMANS, Anti-cancer drugs, 7(8), 1996, pp. 893-896
RANDOMIZED PHASE-II TRIAL COMPARING DIFFERENT DOSES OF THE BISPHOSPHONATE IBANDRONATE IN THE TREATMENT OF HYPERCALCEMIA OF MALIGNANCY
Authors: PECHERSTORFER M HERRMANN Z BODY JJ MANEGOLD C DEGARDIN M CLEMENS MR THURLIMANN B TUBIANAHULIN M STEINHAUER EU VANEIJKEREN M HUSS HJ THIEBAUD D
Citation: M. Pecherstorfer et al., RANDOMIZED PHASE-II TRIAL COMPARING DIFFERENT DOSES OF THE BISPHOSPHONATE IBANDRONATE IN THE TREATMENT OF HYPERCALCEMIA OF MALIGNANCY, Journal of clinical oncology, 14(1), 1996, pp. 268-276
A MULTICENTER, RANDOMIZED STUDY OF 2 SCHEDULES OF PACLITAXEL (PTX) INPATIENTS WITH ADVANCED BREAST-CANCER (ABC)
Authors: PERETZ T SULKES A CHOLLET P GELMON K PARIDAENS R GORBONUVA V CATIMEL G KUHNLE H HUININK WTB KHAYAT D DITTRICH C KLAASSEN U BERGH J WILKING N NABHOLTZ JM CALABRESI F TUBIANAHULIN M CHAZARD M GALLANT G DIERGARTEN K WESTBERG R BOGAERT J RENARD J WEIL C
Citation: T. Peretz et al., A MULTICENTER, RANDOMIZED STUDY OF 2 SCHEDULES OF PACLITAXEL (PTX) INPATIENTS WITH ADVANCED BREAST-CANCER (ABC), European journal of cancer, 31A, 1995, pp. 345-345
TAXOL(R) (PACLITAXEL) 225 MG M(2) BY 3-HOUR INFUSION WITHOUT G-CSF ASA FIRST LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER (MBC)/
Authors: BONNETERRE J TUBIANAHULIN M CHOLLET P CHEVALLIER B FUMOLEAU P KERBRAT P VIE B KHAYAT D TUBIANA N LEJEUNE C LEGRAND A SOARES JA PELLAECOSSET B
Citation: J. Bonneterre et al., TAXOL(R) (PACLITAXEL) 225 MG M(2) BY 3-HOUR INFUSION WITHOUT G-CSF ASA FIRST LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER (MBC)/, European journal of cancer, 31A, 1995, pp. 354-354
HAVE HISTOLOGICAL GRADE NUCLEAR-COMPONENTS (MSBR) OF SCARFF BLOOM RICHARDSON (SBR) A PROGNOSTIC VALUE FOR LOBULAR INVASIVE BREAST-CARCINOMA
Authors: LEDOUSSAL V TUBIANAHULIN M HACENE K SPYRATOS F LASRY S GARBAY JR ROUESSE J
Citation: V. Ledoussal et al., HAVE HISTOLOGICAL GRADE NUCLEAR-COMPONENTS (MSBR) OF SCARFF BLOOM RICHARDSON (SBR) A PROGNOSTIC VALUE FOR LOBULAR INVASIVE BREAST-CARCINOMA, European journal of cancer, 31A, 1995, pp. 666-666
LOW EFFICACY OF 1 HOUR INFUSION HIGH-DOSE IFOSFAMIDE (IFO) IN PREVIOUSLY PRETREATED SARCOMA
Authors: TUBIANAHULIN M CVITKOVIC F LOKIEC F BOZEC L GOUPIL A JANVIER M TURPIN F ROUESSE J
Citation: M. Tubianahulin et al., LOW EFFICACY OF 1 HOUR INFUSION HIGH-DOSE IFOSFAMIDE (IFO) IN PREVIOUSLY PRETREATED SARCOMA, European journal of cancer, 31A, 1995, pp. 871-871
PHENOBARBITAL (PB) INFLUENCE ON IFOSFAMIDE (IF) PHARMACOKINETICS (PK)IN SARCOMA PATIENTS
Authors: LOKIEC F SANTONI J WEILL S TUBIANAHULIN M
Citation: F. Lokiec et al., PHENOBARBITAL (PB) INFLUENCE ON IFOSFAMIDE (IF) PHARMACOKINETICS (PK)IN SARCOMA PATIENTS, European journal of cancer, 31A, 1995, pp. 948-948
PROGNOSTIC FACTOR CLUSTERING IN BREAST-CANCER - BIOLOGY OR CHRONOLOGY
Authors: TUBIANAHULIN M HACENE K MARTIN PM SPYRATOS F
Citation: M. Tubianahulin et al., PROGNOSTIC FACTOR CLUSTERING IN BREAST-CANCER - BIOLOGY OR CHRONOLOGY, European journal of cancer, 31A(2), 1995, pp. 282-283
TOXICITY OF TAXOIDS
Authors: TUBIANAHULIN M
Citation: M. Tubianahulin, TOXICITY OF TAXOIDS, La Semaine des hopitaux de Paris, 71(23-24), 1995, pp. 718-726
ONDANSETRON COMPARED WITH GRANISETRON IN THE PROPHYLAXIS OF CYCLOPHOSPHAMIDE-INDUCED EMESIS IN OUT-PATIENTS - A MULTICENTER, DOUBLE-BLIND, DOUBLE-DUMMY, RANDOMIZED, PARALLEL-GROUP STUDY
Authors: STEWART A MCQUADE B CRONJE JDE GOEDHALS L GUDGEON A CORETTE L FROGER X TUBIANAHULIN M LAPLAIGE P ROBERTS JT MCRAE J FORSTER J PARASURAMAN TV BUTCHER M
Citation: A. Stewart et al., ONDANSETRON COMPARED WITH GRANISETRON IN THE PROPHYLAXIS OF CYCLOPHOSPHAMIDE-INDUCED EMESIS IN OUT-PATIENTS - A MULTICENTER, DOUBLE-BLIND, DOUBLE-DUMMY, RANDOMIZED, PARALLEL-GROUP STUDY, Oncology, 52(3), 1995, pp. 202-210
THE CLINICAL PROGNOSTIC FACTORS IN BREAST -CARCINOMA
Authors: GARBAY JR HACENE K TUBIANAHULIN M YACOUB S ROUESSE J
Citation: Jr. Garbay et al., THE CLINICAL PROGNOSTIC FACTORS IN BREAST -CARCINOMA, Bulletin du cancer, 81(12), 1994, pp. 1078-1084
PROBLEMS IN THE EVALUATION OF TISSULAR PR OGNOSTIC PARAMETERS IN BREAST-CANCER - ABOUT THE CENTER-RENE-HUGUENIN EXPERIENCE
Authors: SPYRATOS F LEDOUSSAL V TUBIANAHULIN M HACENE K ROUESSE J
Citation: F. Spyratos et al., PROBLEMS IN THE EVALUATION OF TISSULAR PR OGNOSTIC PARAMETERS IN BREAST-CANCER - ABOUT THE CENTER-RENE-HUGUENIN EXPERIENCE, Bulletin de l'Academie nationale de medecine, 178(3), 1994, pp. 495-506
SEQUENTIAL IDENTIFICATION OF FACTORS PREDICTING DISTANT RELAPSE IN BREAST-CANCER PATIENTS TREATED BY CONSERVATIVE SURGERY
Authors: TUBIANAHULIN M LEDOUSSAL V HACENE K ROUESSE J BRUNET M
Citation: M. Tubianahulin et al., SEQUENTIAL IDENTIFICATION OF FACTORS PREDICTING DISTANT RELAPSE IN BREAST-CANCER PATIENTS TREATED BY CONSERVATIVE SURGERY, Cancer, 72(4), 1993, pp. 1261-1271
EVALUATION OF BREAST-CARCINOMA CHEMOSENSITIVITY BY FLOW CYTOMETRIC DNA ANALYSIS AND COMPUTER-ASSISTED IMAGE-ANALYSIS
Authors: BRIFFORD M SPYRATOS F HACENE K TUBIANAHULIN M PALLUD C GILLES F ROUESSE J
Citation: M. Brifford et al., EVALUATION OF BREAST-CARCINOMA CHEMOSENSITIVITY BY FLOW CYTOMETRIC DNA ANALYSIS AND COMPUTER-ASSISTED IMAGE-ANALYSIS, Cytometry, 13(3), 1992, pp. 250-258
PARATHYROID-HORMONE RELATED PROTEIN (PTHRP) AND BREAST-CANCER
Authors: DEVERNEJOUL MC BOUIZAR Z LASMOLES F TUBIANAHULIN M SPYRATOS F GUERIS J JULLIENNE A
Citation: Mc. Devernejoul et al., PARATHYROID-HORMONE RELATED PROTEIN (PTHRP) AND BREAST-CANCER, Nouvelle revue francaise d'hematologie, 33(6), 1991, pp. 485-487
Risultati: 1-23 |